.... .... .... .... .... .... .... .... .... .... .... .... .... .... .... .... .... ....
ALBUQUERQUE, N.M. Patients enrolled in the COVID-19-to-Home program receive a console and a finger-touch emergency wrist band to immediately connect with medical professionals.When last fall’s nationwide upsurge in COVID-19 threatened to overwhelm hospitals in New Mexico and elsewhere, Doña Ana County organizations came together to fight the spike with remote-monitoring technology.
Local public and private entities rapidly assembled a novel “COVID-to-Home” program that combined cutting-edge telemedicine with broad community coordination to closely monitor patients at home or in hotel rooms, allowing area hospitals to reserve beds for the most critical COVID-19 patients.
Electronic Caregiver’s “Pro Health” kit for COVID-19-to-Home patients includes a cellular-connected console, an oximeter, a non-touch thermometer, a blood pressure cuff and a wrist band for immediate connection
Residential treatment facilities are implementing Medicaid, other health coverage
Substance use has been a public health issue in America for decades, costing millions of lives and billions of dollars each year. For many, seeking treatment can be an expensive challenge.
But what happens when Medicaid – a program aimed to help low-income families – allows a broader approval for substance use disorder treatment? According to a new study by Indiana University, Johns Hopkins, Temple and Harvard researchers, the number of residential facilities accepting Medicaid increases.
Since its creation in 1965, Medicaid has included the Institutions for Mental Diseases exclusion which prohibits use of federal Medicaid funds to treat enrollees ages 21–64 in psychiatric residential treatment facilities that have more than sixteen beds. However, in 2015, the federal government created a streamlined application pathway for state waivers of this rule to allow Medicaid coverage for substance use